Processa Pharmaceuticals Statistics
Total Valuation
PCSA has a market cap or net worth of $7.37 million. The enterprise value is $1.83 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PCSA has 2.66 million shares outstanding. The number of shares has increased by 969.33% in one year.
| Current Share Class | 2.66M |
| Shares Outstanding | 2.66M |
| Shares Change (YoY) | +969.33% |
| Shares Change (QoQ) | +18.70% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 19.80% |
| Float | 2.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.54
| Current Ratio | 2.54 |
| Quick Ratio | 2.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -372.97% and return on invested capital (ROIC) is -238.00%.
| Return on Equity (ROE) | -372.97% |
| Return on Assets (ROA) | -158.34% |
| Return on Invested Capital (ROIC) | -238.00% |
| Return on Capital Employed (ROCE) | -250.81% |
| Weighted Average Cost of Capital (WACC) | 9.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.11% in the last 52 weeks. The beta is 0.89, so PCSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -73.11% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 5.07 |
| Relative Strength Index (RSI) | 54.29 |
| Average Volume (20 Days) | 45,330 |
Short Selling Information
The latest short interest is 39,505, so 1.49% of the outstanding shares have been sold short.
| Short Interest | 39,505 |
| Short Previous Month | 10,448 |
| Short % of Shares Out | 1.49% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.99M |
| Pretax Income | -13.56M |
| Net Income | -13.56M |
| EBITDA | -13.99M |
| EBIT | -13.99M |
| Earnings Per Share (EPS) | -$10.36 |
Full Income Statement Balance Sheet
The company has $5.54 million in cash and n/a in debt, with a net cash position of $5.54 million or $2.08 per share.
| Cash & Cash Equivalents | 5.54M |
| Total Debt | n/a |
| Net Cash | 5.54M |
| Net Cash Per Share | $2.08 |
| Equity (Book Value) | 5.58M |
| Book Value Per Share | 2.17 |
| Working Capital | 3.43M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -11.39M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,204 |
| Net Borrowing | -6,602 |
| Free Cash Flow | -11.39M |
| FCF Per Share | -$4.28 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PCSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -969.33% |
| Shareholder Yield | n/a |
| Earnings Yield | -184.08% |
| FCF Yield | -154.52% |
Analyst Forecast
The average price target for PCSA is $25.00, which is 802.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 802.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 17, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Dec 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |